Heilongjiang ZBD Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Heilongjiang ZBD Pharmaceutical has a total shareholder equity of CN¥8.3B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 39.5%. Its total assets and total liabilities are CN¥12.9B and CN¥4.5B respectively. Heilongjiang ZBD Pharmaceutical's EBIT is CN¥369.1M making its interest coverage ratio -0.8. It has cash and short-term investments of CN¥1.4B.
Key information
39.5%
Debt to equity ratio
CN¥3.29b
Debt
| Interest coverage ratio | -0.8x |
| Cash | CN¥1.37b |
| Equity | CN¥8.33b |
| Total liabilities | CN¥4.55b |
| Total assets | CN¥12.88b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603567's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥3.0B).
Long Term Liabilities: 603567's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥1.6B).
Debt to Equity History and Analysis
Debt Level: 603567's net debt to equity ratio (23.1%) is considered satisfactory.
Reducing Debt: 603567's debt to equity ratio has reduced from 41.7% to 39.5% over the past 5 years.
Debt Coverage: 603567's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603567 earns more interest than it pays, so coverage of interest payments is not a concern.